SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-036833
Filing Date
2013-05-03
Accepted
2013-05-03 08:51:31
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a13-8304_110q.htm 10-Q 793317
2 EX-10.1 a13-8304_1ex10d1.htm EX-10.1 432885
3 EX-31.1 a13-8304_1ex31d1.htm EX-31.1 12549
4 EX-31.2 a13-8304_1ex31d2.htm EX-31.2 13162
5 EX-32.1 a13-8304_1ex32d1.htm EX-32.1 8476
  Complete submission text file 0001104659-13-036833.txt   6736510

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cldx-20130331.xml EX-101.INS 687820
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldx-20130331.xsd EX-101.SCH 75001
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldx-20130331_cal.xml EX-101.CAL 70976
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cldx-20130331_lab.xml EX-101.LAB 1197290
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldx-20130331_pre.xml EX-101.PRE 536610
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldx-20130331_def.xml EX-101.DEF 323741
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 13810430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances